TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer

Published:2020-06-08 Issue: Volume:26 Page:
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Zhou Fang¹,Wang Meng¹,Aibaidula Mijiti²,Zhang Zhiguo²,Aihemaiti Abudusaimaiti²,Aili Rezhake²,Chen Hao²,Dong Shuangfeng²,Wei Wei²,Maimaitiaili Abulizi²

Affiliation:

1. Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, China (mainland)

2. Department of Cardiothoracic Surgery, People’s Hospital of Hetian, Hetian, Xinjiang, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SMC2 as a potential prognostic biomarker in lung adenocarcinoma and its correlation with immune microenvironment;2024-07-26

2. An axis involving TPX2/hsa-let-7b-5p/TMPO-AS1 promotes lung adenocarcinoma in smokers;Oncology in Clinical Practice;2024-07-10

3. Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma;Biochemical Genetics;2024-06-04

4. High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to the PI3K/Akt pathway through targeted inhibition of TPX2 in endometrial cancer;Cancer Medicine;2024-03

5. Identification of a novel immunogenic death-associated model for predicting the immune microenvironment in lung adenocarcinoma from single-cell and Bulk transcriptomes;Journal of Cancer;2024